BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25813656)

  • 1. Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial.
    Brock G; Montorsi F; Costa P; Shah N; Martinez-Jabaloyas JM; Hammerer P; Ludovico GM; Lee JC; Henneges C; Hamidi K; Rossi A; Mulhall J; Büttner H
    Urology; 2015 May; 85(5):1090-1096. PubMed ID: 25813656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma.
    Gulino G; Sasso F; Palermo G; D'Onofrio A; Racioppi M; Sacco E; Pinto F; Antonucci M; D'Addessi A; Bassi P
    Indian J Urol; 2013 Apr; 29(2):119-23. PubMed ID: 23956513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study.
    Patel HR; Ilo D; Shah N; Cuzin B; Chadwick D; Andrianne R; Henneges C; Barry J; Hell-Momeni K; Branicka J; Büttner H
    BMC Urol; 2015 Apr; 15():31. PubMed ID: 25879460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo.
    Roehrborn CG; Casabé A; Glina S; Sorsaburu S; Henneges C; Viktrup L
    Int J Urol; 2015 Jun; 22(6):582-7. PubMed ID: 25827166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
    Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
    J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis.
    Chen L; Staubli SE; Schneider MP; Kessels AG; Ivic S; Bachmann LM; Kessler TM
    Eur Urol; 2015 Oct; 68(4):674-80. PubMed ID: 25817916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.
    Brundage M; Sydes MR; Parulekar WR; Warde P; Cowan R; Bezjak A; Kirkbride P; Parliament M; Moynihan C; Bahary JP; Parmar MK; Sanders K; Chen BE; Mason MD
    J Clin Oncol; 2015 Jul; 33(19):2151-7. PubMed ID: 26014295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
    Kaplan SA
    J Urol; 2015 May; 193(5):1592-3. PubMed ID: 25895781
    [No Abstract]   [Full Text] [Related]  

  • 9. Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4.
    McElroy WT; Michael Seganish W; Jason Herr R; Harding J; Yang J; Yet L; Komanduri V; Prakash KC; Lavey B; Tulshian D; Greenlee WJ; Sondey C; Fischmann TO; Niu X
    Bioorg Med Chem Lett; 2015 May; 25(9):1836-41. PubMed ID: 25870132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.
    Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA
    Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.
    Ball SG; Atkinson S; Sparks J; Bangs M; Goldberger C; Dubé S
    J Clin Psychopharmacol; 2015 Jun; 35(3):266-72. PubMed ID: 25815754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term recovery of normal sexual function in testicular cancer survivors.
    Capogrosso P; Boeri L; Ferrari M; Ventimiglia E; La Croce G; Capitanio U; Briganti A; Damiano R; Montorsi F; Salonia A
    Asian J Androl; 2016; 18(1):85-9. PubMed ID: 26112476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent effect of androgen deprivation therapy for localized prostate cancer on adverse cardiac events.
    Schmid M; Sammon JD; Reznor G; Kapoor V; Speed JM; Abdollah FA; Sood A; Chun FK; Kibel AS; Menon M; Fisch M; Sun M; Trinh QD
    BJU Int; 2016 Aug; 118(2):221-9. PubMed ID: 26074405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.
    Daouacher G; von Below C; Gestblom C; Ahlström H; Grzegorek R; Wassberg C; Sörensen J; Waldén M
    BJU Int; 2016 Jul; 118(1):77-83. PubMed ID: 26074275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we targeting the right outcome for sexual health after prostate cancer treatment?
    Wittmann D; Skolarus TA; Montie JE
    Eur Urol; 2015 Oct; 68(4):550-1. PubMed ID: 26058958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications and effectiveness of treatment of patients with locally advanced prostate cancer after combined radiotherapy and radical prostatectomy with postoperative radiotherapy].
    Solodky VA; Pavlov AY; Panshin GA; Tsybulsky AD; Garmash SV; Isaev TK; Kravtsov IB
    Vopr Onkol; 2015; 61(1):145-8. PubMed ID: 26016162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.
    Zhang X; Zeng X; Dong L; Zhao X; Qu X
    World J Urol; 2015 Dec; 33(12):2071-7. PubMed ID: 25850975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial (Urology 2015;85:1090-1096).
    Culha MG; Pastuszak A; Serefoglu EC
    Urology; 2015 Dec; 86(6):1242-3. PubMed ID: 26404057
    [No Abstract]   [Full Text] [Related]  

  • 19. Gout is associated with organic and psychogenic erectile dysfunction.
    Hsu CY; Lin CL; Kao CH
    Eur J Intern Med; 2015 Nov; 26(9):691-5. PubMed ID: 26089189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus.
    Elkelany OO; Owen RC; Kim ED
    Ther Clin Risk Manag; 2015; 11():507-13. PubMed ID: 25848297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.